alexion rare disease portfolio

Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare dise

7 Myths About Rare Disease Data Center Exposed

In 2026 Alexion presented the largest share of therapeutic classes for rare diseases at the AAN meeting, highlighting that data hubs are not the only drivers of innovation. The claim that a single rare disease data center controls all insight is therefore inaccurate. My experience working with multiple registries confirms

alexion rare disease portfolio

7 Myths About Rare Disease Data Center Exposed

In 2026 Alexion presented the largest share of therapeutic classes for rare diseases at the AAN meeting, highlighting that data hubs are not the only drivers of innovation. The claim that a single rare disease data center controls all insight is therefore inaccurate. My experience working with multiple registries confirms

alexion rare disease portfolio

7 Myths About Rare Disease Data Center Exposed

In 2026 Alexion presented the largest share of therapeutic classes for rare diseases at the AAN meeting, highlighting that data hubs are not the only drivers of innovation. The claim that a single rare disease data center controls all insight is therefore inaccurate. My experience working with multiple registries confirms